Document is current
Any future updates will be listed below
-
Authors
Valsecchi, Anna Amela
Di Maio, Massimo https://orcid.org/0000-0001-8906-3785
-
Funding
Funding for this research was provided by:
Università degli Studi di Torino
- License Information
-
More Information
Article History
Accepted: 28 April 2025
First Online: 14 May 2025
Declarations
:
: Open access funding provided by Università degli Studi di Torino within the CRUI-CARE Agreement.
: Anna Amela Valsecchi declares she has no conflict of interest. Massimo Di Maio reports honoraria from AstraZeneca, Boehringer Ingelheim, Janssen, Merck Sharp & Dohme (MSD), Novartis, Pfizer, Roche, GlaxoSmithKline, Takeda, Viatris, Eisai, Daiichi Sankyo for consultancy or participation on advisory boards and institutional funding for work in clinical trials / contracted research from BeiGene, Exelixis, MSD, Pfizer and Roche.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the conception. Literature search and data analysis were performed by Anna Amela Valsecchi and Massimo Di Maio. The first draft of the manuscript was written by Anna Amela Valsecchi and Massimo Di Maio critically revised it. All authors read and approved the final manuscript.
